ASH vs. NVZMY: Which Stock Is the Better Value Option?

Core Viewpoint - Investors in the Chemical - Specialty sector should consider Ashland (ASH) and Novozymes A/S (NVZMY) as potential value stocks, with ASH currently presenting a more favorable valuation based on key metrics [1][3]. Valuation Metrics - ASH has a forward P/E ratio of 20.82, while NVZMY has a significantly higher forward P/E of 33.53 [2]. - ASH's PEG ratio is 0.91, indicating a more attractive valuation relative to its expected earnings growth, compared to NVZMY's PEG ratio of 3.44 [2]. - ASH's P/B ratio stands at 1.52, which is considerably lower than NVZMY's P/B ratio of 13.68, suggesting ASH is undervalued relative to its book value [3]. Investment Outlook - Both ASH and NVZMY have a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook for both companies [1]. - ASH holds a Value grade of B, while NVZMY has a Value grade of F, reinforcing ASH as the superior value option based on current valuation figures [3].